U.S. Stock Futures Recover From Earlier Decline Pre-Bell, Now Flat Amid Earnings Beats, Encouraging Data


Shutterstock photo

U.S. stock futures recovered ground before the market open Thursday, trading flat to higher recently as encouraging economic data and a slew of better-than-expected quarterly results lifted stocks.

The latest round of economic data showed January durable-goods orders fell by 1.0%, smaller than the 1.5% decline that was expected. However, December durable-goods orders were revised downward to a 5.3% drop from a 4.3% drop initially.

Separately, initial jobless claims for the week ended Feb. 22 were up 14,000 at 348,000, below the 335,000 consensus. Claims in the week ended Feb. 15 were revised downward to 334,000 from 336,000.

Later Thursday, Federal Reserve Chair Janet Yellen will testify in front of the Senate Banking Committee. It is the second day of her semi-annual monetary policy testimony, which was delayed due to weather. On her first day, she didn't express considerable worry about emerging-markets financial-market volatility or a recent set of weaker U.S. data. She also had said the Fed would likely require "notable" change in the outlook for it to pause or increase the pace of tapering from its now $75 billion-a-month asset-purchasing program.

In equities, department-store operator J.C.Penney ( JCP ) soared 23% in recent pre-market trading after reporting Q4 results that beat analysts expectations. Consumer-electronics retailer Best Buy ( BBY ) rose over 7% pre-market as its Q4 EPS exceeded the average consensus, even as sales fell more than expected.


-Dow Jones Industrial unchanged

-S&P 500 futures down 0.03%

-Nasdaq 100 futures up 0.14%

-Nasdaq-100 Pre-Market Indicator down 0.01%


Nikkei down 0.32%

Hang Seng up 1.74%

Shanghai Composite down 0.43%

FTSE-100 down 0.24%

DAX-30 down 1.02%


(+/-) Large cap tech: mixed

(-) Chip stocks: lower

(-) Software stocks: lower

(-) Hardware stocks: flat to lower

(+/-) Internet stocks: mixed

(+/-) Drug stocks: mixed

(+/-) Financial stocks: mixed

(+/-) Retail stocks: mixed

(-) Industrial stocks: flat to lower

(-) Airlines: lower

(+/-) Autos: mixed


(+) BIDU (+3.0%) Projects Q1 sales ahead of views

(+) CRDC (+8.11%) Gets FDA OK for microcutter for stapling of thin tissue

(+) DANG (+10.9%) Posts surprise Q4 profit, revenue beat

(+) PEIX (+25.6%) Q4 results far exceed expectations

(+) YRCW (+8.3%) Earnings beat views


(-) WEN (-2.2%) Reiterates FY EPS guidance at low end of views

(-) RBS (-7.1%) Reports Q4 pre-tax loss of GBP8.24 billion

(-) HLT (-1.4%) Q4 misses views, sets Q1 guidance below street

(-) RL (-1.2%) Slips despite Goldman upgrade

(-) INO (-11.8%) Plans public share sale

(-) CTRX (-12.0%) Slips on Q4 results, guidance

(-) CHS (-4.4%) Q4 earnings miss views, same-store sales drop

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities
More Headlines for: JCP , BBY

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com